Viralgen Vector Core  

San Sebastian, 
Spain
http://viralgenvc.com

Welcome to ASGCT and Viralgen Vector Core.

Viralgen is a CDMO that specializes in development through large-scale commercial production of cGMP certified rAAV for cell and gene therapies. Through our proprietary Pro10™ suspension manufacturing platform, we deliver industry-leading titers for all AAV serotypes to our client partners, optimizing speed to market and cost-of-goods to accelerate clinical development and commercialization. The company’s state-of-the-art facilities based in San Sebastian, Spain include a commercial facility consisting of three modules, each having three cGMP suites with capacities of >2,000 L.

 Show Specials

• Ask About 2000 L rAAV Production (Feb 20, 2024)
  We have successfully manufactured >11 batches of rAAV at the 2,000 L scale. Ask us about our large scale production and technical transfer capabilities.

 Press Releases

• Elpida Therapeutics Partners with Viralgen (Feb 20, 2024)
  Viralgen and Elpida Tx have partnered to manufacture AAV9-based gene therapies for patients living with SPG50 and CMT4J. 

 Products